Generics are used in 90% of U.S. prescriptions but only 15% of spending. Across the world, providers see them as essential tools-but for wildly different reasons. From Europe's cost-control systems to India's life-saving supply chains, how countries view generics reveals deeper truths about healthcare priorities.
Details